Bernard Morton Borgida, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 30045 Avenida Elegante, Rancho Palos Verdes, CA 90275 Phone: 310-544-7775 |
News Archive
Patients who rely on recombinant, protein-based drugs must often endure frequent injections, often several times a week, or intravenous therapy. Researchers at Children's Hospital Boston demonstrate the possibility that blood vessels, made from genetically engineered cells, could secrete the drug on demand directly into the bloodstream.
Today, eHealthInsurance.com (NASDAQ: EHTH), the leading online source of health insurance for individuals, families and small businesses, released data comparing non-group health insurance premiums for policies available at eHealth in the state of California, and subsidized COBRA premiums for people in California.
Ortho Development Corporation has received FDA clearance for its patented KASM Knee Articulating Spacer Molds. KASM is a cement spacer mold intended for use in treating patients who develop an infection after undergoing total knee replacement surgery.
"In mid-July, ... the near-final draft of the independent evaluation of the Affordable Medicines Facility - Malaria (AMFm) was released," Victoria Fan, a research fellow at the Center for Global Development (CGD), and Heather Lanthorn, a doctoral candidate at Harvard School of Public Health, write in this post in the center's "Global Health Policy" blog.
Celsion Corporation announced today that after reviewing safety data from the 40mg/m2 cohort, the DIGNITY Study Drug Safety Monitoring Board (DSMB) has recommended that Celsion continue to enroll patients in the trial and that new patients be treated at a ThermoDox® dose of 50mg/m2.
› Verified 6 days ago